Bacterial or Viral Lung Infection? UPMC Studying Blood Test

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Bacterial or Viral Lung Infection? UPMC Studying Blood Test That Could Reduce Antibiotic Use

PITTSBURGH, Nov. 11, 2014 (GLOBE NEWSWIRE) -- via PRWEB - A new blood biomarker test that indicates whether bacteria is the cause of a patient's lung infection is now being studied at UPMC Presbyterian, launching a national multicenter trial. The information could help doctors decide when to prescribe antibiotics and possibly reduce overuse of the drugs, which can lead to antibiotic-resistant strains of bacteria.

Patients who go to hospital emergency departments (ED) with coughs and breathing difficulties could have pneumonia, bronchitis, asthma or chronic obstructive pulmonary disease, or even congestive heart failure, explained principal investigator David T. Huang, M.D., M.P.H., associate professor of critical care medicine and emergency medicine, University of Pittsburgh School of Medicine . Aaron Brown, M.D., assistant professor of emergency medicine, and Franziska Jovin, M.D., associate professor of medicine, will lead the study in the ED and hospital.

"Doctors prescribe antibiotics more often than they would like to because it can be really hard to tell if a patient has a lung infection or a non-infectious disease," he said. "Also, viral infections look very much like bacterial infections, and X-rays typically cannot distinguish between the two. This study will examine whether a novel biomarker can help doctors make more informed decisions about using antibiotics."

More than 1,500 lung infection patients will be needed to complete the Procalcitonin Antibiotic Consensus Trial (ProACT), which will eventually be expanded to include approximately 10 other sites across the country.

Patients diagnosed in the ED with a lung infection and who are not critically ill will be asked to join ProACT. If they agree, patients will be randomly assigned to either get usual care or to also have a blood test to measure the level of the protein procalcitonin, which previous Swiss studies have shown is high with bacterial infection and low with viral infection. The result and a recommendation about antibiotic use will be available within an hour to the treating ED physician. If the patient is admitted to the hospital, follow-up procalcitonin levels will be checked and made available to the treating hospital physician. The research team will call study patients twice within 30 days of the ED visit to check on their health status and the period of antibiotic use, if any.

"The final decision to use or not use antibiotics is up to the doctor, who also will be taking into account the patient's medical history and other factors," Dr. Huang said. "My hope is that we'll find that patient outcomes are as just as good, while antibiotic use declines."

ProACT is funded by a $5 million, five-year grant, and a one-year trial planning grant, from the National Institute of General Medical Sciences, part of the National Institutes of Health.

About the University of Pittsburgh School of Medicine

As one of the nation's leading academic centers for biomedical research, the University of Pittsburgh School of Medicine integrates advanced technology with basic science across a broad range of disciplines in a continuous quest to harness the power of new knowledge and improve the human condition. Driven mainly by the School of Medicine and its affiliates, Pitt has ranked among the top 10 recipients of funding from the National Institutes of Health since 1998. In rankings recently released by the National Science Foundation, Pitt ranked fifth among all American universities in total federal science and engineering research and development support.

Likewise, the School of Medicine is equally committed to advancing the quality and strength of its medical and graduate education programs, for which it is recognized as an innovative leader, and to training highly skilled, compassionate clinicians and creative scientists well-equipped to engage in world-class research. The School of Medicine is the academic partner of UPMC, which has collaborated with the University to raise the standard of medical excellence in Pittsburgh and to position health care as a driving force behind the region's economy. For more information about the School of Medicine, see http://www.medschool.pitt.edu .

http://www.upmc.com/media

This article was originally distributed on PRWeb. For the original version including any supplementary images or video, visit http://www.prweb.com/releases/2014/11/prweb12315290.htm

UPMC Richard Pietzak +1 (412) 647-6190

Scroll down for more posts ▼

Top 10 Most Recent News Articles

MacDill Mold Case Puts Privatized Housing on Notice

Updated Category News Views 226

Four hundred fifty-four people are a hard number to shrug off. The expanded civil case over alleged toxic mold conditions at MacDill Air Force Base now covers 105 military families, up from 39 households when it was filed in September 2025. Their complaint against The Michaels Organization and affiliated entities may be the largest known military-housing lawsuit in the...

Continue Reading
Vector's Peptide Pact Needs Proof Before Any Payday

Updated Category News Views 174

A famous orthopedic name can open doors, but it cannot manufacture clinical evidence. That is the plain reality behind Vector Science and Therapeutics' new collaboration with the Andrews Research & Education Foundation. Dr. James Andrews carries enormous credibility in sports medicine, earned across more than five decades of work. For Vector, that association matters. For...

Continue Reading
Sunbit’s 2027 Loan Push Meets an NVIDIA-Fueled Tape

Updated Category News Views 116

Credit Is About to Enter Sunbit’s Growth Story Sunbit has spent years building a point-of-sale fintech footprint, and the numbers it cited on November 18 make the next step harder to dismiss as mere marketing fluff. The company says it has topped 400,000 activated cardholders and 50,000 merchants, while expecting more than $440 million in fiscal 2026 sales on greater...

Continue Reading
Lummus-Versalis Deal Adds Nine Elastomer Technologies

Updated Category News Views 93

Nine elastomer technologies do not make a flashy headline, yet this is the sort of chemical-industry move that can matter long after the applause dies down. Lummus Technology and Versalis have expanded their partnership to cover nine elastomer technologies. That is the disclosed fact, and it is meaningful on its own. The release does not lay out contract value, duration,...

Continue Reading
DigiKey’s Arduino Webinar Puts Edge AI Hardware to Work

Updated Category News Views 62

A Small Board With a Big Practical Question Edge AI is finally getting dragged out of the slide deck and onto the workbench, which is where it ought to prove itself. DigiKey plans to host a free 60-minute webinar on Dec. 2, 2026, at 10 a.m. CST covering Arduino’s new VENTUNO Q edge AI computer. The session promises a hardware tour, an Arduino App Lab walkthrough, and a...

Continue Reading
AMP Tests Debt Market With €1.25 Billion Green Notes

Updated Category News Views 167

Refinancing season has arrived early at Ardagh Metal Packaging, and it is carrying a hefty €1.25 billion price tag. AMP has launched senior secured floating-rate green notes, with proceeds intended to retire two batches of secured debt due in 2028 and leave additional cash on the balance sheet for general corporate purposes, including capital expenditure. This is not...

Continue Reading
Breakthrough T1D Gala Puts Research Progress First

Updated Category News Views 49

One person living without insulin after a cell-therapy trial is the detail that cuts through all the ballroom polish tonight. Breakthrough T1D's 53rd Annual New York City Promise Gala lands at the Plaza Hotel during National Diabetes Awareness Month, and it carries a message worth handling carefully: research can produce extraordinary outcomes, but one participant's...

Continue Reading
Scenthound’s Franchise Award Spotlights a Real Test

Updated Category News Views 30

A clean dog may not sound like a growth story, yet Scenthound has turned that neglected chore into a surprisingly serious franchise proposition. The company has won the International Franchise Association’s Emerging Franchisor Award after building its dog-hygiene concept from a 2015 founding into a network with more than 180 open locations. That is a respectable piece...

Continue Reading
Voltage Energy's Microgrid Launches at RE+ 2026

Updated Category News Views 201

Voltage Energy Unveils New Power Systems In the swirling chaos of energy innovation, Voltage Energy is trying to carve its path at the heart of RE+ 2026. Out in Las Vegas, amidst the buzz of renewable energy tech, they introduced their Microgrid System (MGS) along with two new electrical balance of system (EBOS) products—the Load Break Disconnect Box (LBD) and Combiner...

Continue Reading
BetterInvesting Puts ELMD and FIVE Under a Fresh Lens

Updated Category News Views 74

Two familiar market traps are hiding in this otherwise useful announcement: mistaking a study candidate for a buy signal, and treating the word undervalued like it fell from a mountaintop. BetterInvesting has named Electromed Inc. as its “Stock to Study” and Five Below Inc. as its “Undervalued Stock” for the January-February 2027 issue of its magazine. That is...

Continue Reading

Top 5 Most Recently Viewed Articles

Balaji Srinivasan Links Bitcoin to Wealth and Health Preservation

Updated Category News Views 54

Balaji Srinivasan's Views on Bitcoin's Role Balaji Srinivasan, the former CTO of Coinbase, has been in the spotlight for his insights on how Bitcoin can help protect personal wealth. He draws a compelling comparison between Bitcoin and the pursuit of longevity in healthcare, suggesting both serve as defenses against state control over personal lives. Bitcoin as a Shield...

Continue Reading
Sequana Medical to Host Webinar on alfapump Commercial Launch

Updated Category News Views 213

Sequana Medical's Upcoming KOL Webinar on alfapump Launch Sequana Medical is set to host a Key Opinion Leader (KOL) webinar focused on the alfapump, designed for tackling recurrent and refractory ascites due to liver cirrhosis. This engaging session will take place on January 8. Experts from esteemed institutions will dive into vital discussions about the alfapump's...

Continue Reading
Qualcomm's Strategies to Navigate Competitive Market Pressures

Updated Category News Views 196

Qualcomm's Strong Market Position Despite Challenges Qualcomm Inc (NASDAQ: QCOM) has shown impressive resilience in the market, achieving significant growth largely due to its core chip business, which has seen double-digit growth. This is an encouraging sign of ongoing demand for its technology, particularly with high-end Android devices and innovations within artificial...

Continue Reading
Healthcare Providers Speak: A Study on Challenges and Care

Updated Category News Views 216

Healthcare Providers Speak: A Study on Challenges and Care Shapiro+Raj, a premier insights and strategy consultancy, has unveiled a significant study titled The Provider Perspective: Insights on Policy, Practice, and Patient Care. This comprehensive four-part series delves into the experiences of healthcare providers in the United States, highlighting their readiness to...

Continue Reading
PBOC Executes Groundbreaking Swap Operation of 50 Billion Yuan

Updated Category News Views 101

PBOC's Innovative Swap Operation The People's Bank of China (PBOC) has made waves in the financial sector by executing its very first swap operation involving a remarkable 50 billion yuan, equivalent to approximately 7.03 billion dollars. This pivotal event took place on a Monday, signifying a strategic move in China's monetary policy. Significance of the Swap Operation...

Continue Reading